Selank — Russian-developed heptapeptide research compound. Synthetic tuftsin analog studied for anxiolytic and nootropic activity.

Selank is a synthetic heptapeptide research compound developed at the Institute of Molecular Genetics in Russia. It is based on the immunomodulatory peptide tuftsin with an extended C-terminal sequence for stability.
Selank’s mechanism is studied to involve enkephalin and GABAergic systems, with effects on BDNF expression. Unlike benzodiazepines, it does not produce dependence in research models.
Used in: anxiolytic peptide research, nootropic studies, BDNF research, comparative tuftsin analog studies.
| Compound | Selank |
| Available Strengths | 5mg, 10mg |
| Purity | ≥99% (verified by HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Reconstitution | Bacteriostatic water (sold separately) |
| Shelf Life | 36 months (lyophilized, properly stored) |
| Certificate of Analysis | Available upon request — contact us |
Add bacteriostatic water slowly. Use within 28 days.
Lyophilized: -20°C. Reconstituted: 2-8°C.
For research use only. Not for human consumption.